Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 SnapShot: non-small cell lung cancer.

Literature DB >> 22439939

SnapShot: non-small cell lung cancer.

Rebecca S Heist¹, Jeffrey A Engelman.

Abstract

Entities: Disease

Mesh：

Substances：
Neoplasm Proteins

Year: 2012 PMID： 22439939 DOI： 10.1016/j.ccr.2012.03.007

Source DB: PubMed Journal: Cancer Cell ISSN： 1535-6108 Impact factor: 31.743

Keyword Cloud
Cited

× No keyword cloud information.

93 in total

1. Analysis of the molecular and clinicopathologic features of surgically resected lung adenocarcinoma in patients under 40 years old.

Authors: Ting Ye; Yunjian Pan; Rui Wang; Haichuan Hu; Yang Zhang; Hang Li; Lei Wang; Yihua Sun; Haiquan Chen
Journal: J Thorac Dis Date: 2014-10 Impact factor: 2.895

2. miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.

Authors: Hongwei Liang; Minghui Liu; Xin Yan; Yong Zhou; Wengong Wang; Xueliang Wang; Zheng Fu; Nan Wang; Suyang Zhang; Yanbo Wang; Ke Zen; Chen-Yu Zhang; Dongxia Hou; Jing Li; Xi Chen
Journal: J Biol Chem Date: 2014-11-12 Impact factor: 5.157

3. Up-front polytherapy for ALK-positive lung cancer.

Authors: Bingying Zhou; Adrienne D Cox
Journal: Nat Med Date: 2015-09 Impact factor: 53.440

4. The evolving role of the pathologist in the management of lung cancer.

Authors: Adi F Gazdar
Journal: Lung Cancer Manag Date: 2012

5. LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response.

Authors: Fuming Li; Xiangkun Han; Fei Li; Rui Wang; Hui Wang; Yijun Gao; Xujun Wang; Zhaoyuan Fang; Wenjing Zhang; Shun Yao; Xinyuan Tong; Yuetong Wang; Yan Feng; Yihua Sun; Yuan Li; Kwok-Kin Wong; Qiwei Zhai; Haiquan Chen; Hongbin Ji
Journal: Cancer Cell Date: 2015-04-30 Impact factor: 31.743

SnapShot: non-small cell lung cancer.

1. Analysis of the molecular and clinicopathologic features of surgically resected lung adenocarcinoma in patients under 40 years old.

2. miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4.

3. Up-front polytherapy for ALK-positive lung cancer.

4. The evolving role of the pathologist in the management of lung cancer.

5. LKB1 Inactivation Elicits a Redox Imbalance to Modulate Non-small Cell Lung Cancer Plasticity and Therapeutic Response.

6. Down-regulation of miR-452 is associated with poor prognosis in the non-small-cell lung cancer.

Review 7. DNA repair pathways and their roles in drug resistance for lung adenocarcinoma.

8. Elevated plasma interleukin-35 levels predict poor prognosis in patients with non-small cell lung cancer.

9. Coordinate direct input of both KRAS and IGF1 receptor to activation of PI3 kinase in KRAS-mutant lung cancer.

10. Mcl-1 mediates TWEAK/Fn14-induced non-small cell lung cancer survival and therapeutic response.